Skip to search formSkip to main contentSkip to account menu

Metastron

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2009
Highly Cited
2009
2001
2001
  • P. Windsor
  • Clinical oncology (Royal College of Radiologists…
  • 2001
  • Corpus ID: 8826307
An analysis of prospectively collected data from 75 patients with bone metastases secondary to prostate cancer who were treated… 
Review
2001
Review
2001
In the United States in 2000, 180,400 new cases of prostate carcinoma were expected to occur, with 31,900 men expected to die… 
2001
2001
Abstract. Spinal cord compression (SCC) is a devastating complication of metastatic cancer. We investigated the potential… 
Review
2000
Review
2000
  • A. McEwan
  • Seminars in radiation oncology
  • 2000
  • Corpus ID: 26015902
Highly Cited
2000
Highly Cited
2000
Abstract. This retrospective study evaluated the toxicity and efficacy of strontium-89 chloride (Metastron, Amersham) in 94… 
1996
1996
Strontium-89 chloride (Metastron) is an FDA-approved treatment for palliation of cancer pain. We evaluated blood count changes… 
Highly Cited
1994
Highly Cited
1994
A retrospective study was performed on the cost-effectiveness of treatment for advanced prostate cancer metastatic to bone… 
Highly Cited
1994
Highly Cited
1994
The objectives of the study were to estimate the cost of medical care for patients recruited into the Trans Canada trial of… 
Review
1994
Review
1994
  • A. Porter
  • European urology
  • 1994
  • Corpus ID: 22578133
Bone metastases that develop in patients with advanced prostate cancer often cause deep, unremitting pain. Palliative options for…